News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biocryst Pharmaceuticals (BCRX) Files For Government-Funded Flu Treatment


12/20/2013 8:15:22 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Durham drug developer BioCryst (Nasdaq: BCRX) has filed its first New Drug Application – for government-funded flu treatment peramivir. Rob Bennett, vice president of investor relations and operations, calls today a "history day" for the company. This time last year, today seemed unlikely.

Help employers find you! Check out all the jobs and post your resume.


comments powered by Disqus
   
Influenza

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES